Prothena Corporation plc
PRTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $4 | $3 | $2 |
| % Growth | -45.4% | 56.3% | 33.2% | – |
| Cost of Goods Sold | $29 | $0 | $0 | $0 |
| Gross Profit | -$27 | $4 | $3 | $2 |
| % Margin | -1,098.3% | 100% | 100% | 100% |
| R&D Expenses | $29 | $41 | $51 | $50 |
| G&A Expenses | $13 | $16 | $18 | $17 |
| SG&A Expenses | $13 | $16 | $18 | $17 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$28 | $33 | $0 | $0 |
| Operating Expenses | $14 | $89 | $68 | $67 |
| Operating Income | -$40 | -$85 | -$66 | -$65 |
| % Margin | -1,666.3% | -1,914.4% | -2,319% | -3,056.9% |
| Other Income/Exp. Net | $4 | $4 | $4 | $5 |
| Pre-Tax Income | -$36 | -$81 | -$61 | -$60 |
| Tax Expense | $0 | $45 | -$1 | -$2 |
| Net Income | -$37 | -$126 | -$60 | -$58 |
| % Margin | -1,513.1% | -2,845.4% | -2,128.5% | -2,729.9% |
| EPS | -0.68 | -2.34 | -1.12 | -1.08 |
| % Growth | 70.9% | -108.9% | -3.7% | – |
| EPS Diluted | -0.68 | -2.34 | -1.12 | -1.08 |
| Weighted Avg Shares Out | 54 | 54 | 54 | 54 |
| Weighted Avg Shares Out Dil | 54 | 54 | 54 | 54 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $4 | $4 | $5 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$36 | -$52 | -$65 | -$65 |
| % Margin | -1,488.2% | -1,171.5% | -2,311.1% | -3,046.4% |